Cargando…
Biomarkers of Alzheimer’s Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Alzheimer’s disease (AD) is a progressive degenerative disorder of the brain and is the most common form of dementia. To-date no simple, inexpensive and minimally invasive procedure is available to confirm with certainty the early diagnosis of AD prior to the manifestations of symptoms characteristi...
Autores principales: | François, Maxime, Leifert, Wayne, Martins, Ralph, Thomas, Philip, Fenech, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166904/ https://www.ncbi.nlm.nih.gov/pubmed/24938500 http://dx.doi.org/10.2174/1567205011666140618103827 |
Ejemplares similares
-
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer’s Disease in the AIBL Study of Ageing
por: Siddiqui, Mohammad Sabbir, et al.
Publicado: (2020) -
Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease
por: François, Maxime, et al.
Publicado: (2022) -
Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022) -
Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration
por: François, Maxime, et al.
Publicado: (2021) -
Focus on Peripheral Biomarkers of Mental Disorders
por: Bartoli, Francesco, et al.
Publicado: (2022)